The role of nonsteroidal antiinflammatory drugs in ocular inflammation

International Ophthalmology Clinics

Volumn 36, Issue 1, 1996, Pages 195-206

  Samiy, Nasrollah ^b   Foster, C Stephen ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKANOIC ACID; AMINOPHENOL DERIVATIVE; CORTICOSTEROID; DICLOFENAC; DIFLUNISAL; FENAMIC ACID DERIVATIVE; FENOPROFEN CALCIUM; INDOLE DERIVATIVE; INDOMETACIN; MECLOFENAMATE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLACETIC ACID; PHENYLBUTAZONE; PYRAZOLONE DERIVATIVE; SALICYLIC ACID DERIVATIVE;

ALLERGIC CONJUNCTIVITIS; CATARACT EXTRACTION; CLINICAL TRIAL; DRUG CLASSIFICATION; DRUG EFFICACY; EPISCLERITIS; EYE INFLAMMATION; HUMAN; ORAL DRUG ADMINISTRATION; PAPILLARY CONJUNCTIVITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RETINA MACULA CYSTOID EDEMA; REVIEW; SCLERITIS; TOPICAL DRUG ADMINISTRATION; UVEITIS; VISION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ADMINISTRATION ROUTES; ENDOPHTHALMITIS; HUMANS;

EID: 0029871305     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199603610-00019     Document Type: Review

References (39)

1. Flack AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992;36: 259-284
2. Gilman AG, Rall TC, Nies AS, Taylor P. The pharmacologic basis of therapeutics. Elmsford: Pergamon, 1990:638-681
3. Abramson SB, Weissman G. The mechanism of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1989;32:1-9
4. Eakins KE. Prostaglandins and non-prostaglandin-mediated breakdown of the blood-aqueous barrier. Exp Eye Res (suppl) 1977;80:483-498
5. Sand BB, Krogh E. Topical indomethacin, a prostaglandin inhibitor, in acute anterior uveitis. A controlled clinical trial of non-steroid versus steroid anti-inflammatory treatment. Acta Ophthalmol (Copenh) 1991;69:145-148
6. Miyake K, Sugiyama S, Narimatsu I, et al. Prevention of cystoid macular edema after lens extraction by topical indomethacin: III. Radioimmunoassay measurement of prostaglandins in the aqueous during and after lens extraction procedures. Albrecht von Graefes Arch Klin Exp Ophthalmol 1978;209:83-88
7. Unger WG, Bass MS. Prostaglandins and nerve-mediated response of the rabbit eye to argon laser irradiation of the iris. Ophthalmologica 1977;175:153-158
8. Flach AJ, Stegman RG, Graham J, et al. Prophylaxis of aphakic cystoid macular edema without corticosteroids. Ophthalmology 1990;97:1253-1258
9. Jampol LM, Sanders DR, Kraff MC. Prophylaxis and therapy of aphakic cystoid macular edema. Surv Ophthalmol 1984;28:535-539
10. Spaide RF, Yannuzi LA. Cystoid macular edema after cataract surgery. Semin Ophthalmol 1993;8:121-129
11. Wright PL, Wilkinson CP, Balyeat HD, et al. Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol 1988;106:740-744
12. Mishima H, Masuda K, Miyake K. The putative role of prostaglandins in cystoid macular edema. Prog Clin Biol Res 1989;31:251-264
13. Miyake K, Sahamura S, Miura H. Long-term follow-up study on the prevention of aphakic cystoid macular edema by topical indomethacin. Br J Ophthalmol 1980;64: 324-328
14. Solomon LD, Flurbiprofen-CME Study Group. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. J Cataract Refract Surg 1995;21:73-81
15. Ginsburg AP, Cheetham JK, DeGryse RE, et al. Effects of flurbiprofen and indomethacin on acute cystoid macular edema after cataract surgery: functional vision and contrast sensitivity. J Cataract Refract Surg 1995;21:82-92
16. Burnett J, Tessler H, Isenberg S, et al. Double-masked trial of fenprofen sodium: treatment of chronic aphakic cystoid macular edema. Ophthalmic Surg 1983;14: 150-152
17. Flach AJ, Dolan BJ, Irvine AR. Effectiveness of ketorolac 0.5% solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol 1987;103: 479-486
18. Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 1991;112:514-519
19. Flach AJ, Stegman RC, Graham J, et al. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 1990;97:1253-1258
20. Sanders DR, Kraff ML. Steroidal and nonsteroidal anti-inflammatory agents. Effects on postsurgical inflammation and blood-aqueous barrier breakdown. Arch Ophthalmol 1984;102:1453-1456
21. Sabiston MB, Tessler D, Sumersk H, et al. Reduction of inflammation following cataract surgery by flurbiprofen. Ophthalmic Surg 1987;18:873-877
22. Flach AJ, Graham J, Kruger LP, et al. Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of ketorolac tromethamine solution. A double-masked, paired comparison with vehicle-placebo solution study. Arch Ophthalmol 1988;106:344-347
23. Flach AJ, Lavelle CJ, Olander KW, et al. The effect of ketorolac 0.5% solution in reducing postsurgical inflammation following ECCE with IOL. Double-masked, parallel comparison with vehicle. Ophthalmology 1988;95:1279-1284
24. Vickers FF, McGuigan LJB, Ford C, et al. The effect of diclofenal sodium ophthalmic on the treatment of postoperative inflammation. Invest Ophthalmol Vis Sci (ARVO suppl) 1991;32:793
25. Flach AJ, Kraff MC, Sanders DR, et al. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier. Arch Ophthalmol 1988;106:480-483
26. Kraff MC, Sanders DR, McGuigan L, et al. Inhibition of blood-aqueous humor barrier breakdown with diclofenac. A fluorophotometric study. Arch Ophthalmol 1990;108:380-383
27. Young BJ, Cunningham WF, Akingkein T. Double-masked, controlled clinical trial of 5% versus 0.5% prednisolone versus 0.9% saline in acute endogenous nongranulomatous anterior uveitis. Br J Ophthalmol 1982;26:389-391
28. Sand BB, Krogh E. Topical indomethacin, a prostaglandin inhibitor, in acute anterior uveitis. A controlled trial of non-steroid versus steroid anti-inflammatory treatment. Acta Ophthalmol 1991;69:145-148
29. Olsen NY, Lindsley CB, Godfrey WA. Nonsteroidal anti-inflammatory drug therapy in childhood iridocyclitis. Am J Dis Child 1988;142:1289-1292
30. Giordano M. Daverprophylaxe der rezidivienenden "spondylitischen iridocyclitis" durch antimalarica und nichtsteroidale antiphlogistica. Z Rheumatol 1983;41: 105-106
31. Vitale A, Foster CS. Nonsteroidal anti-inflammatory drugs. In: Zimmerman TJ, ed. Textbook of ocular pharmacology. New York: Lippincott-Raven, 1995 (in press)
32. Lyons CJ, Hakin KN, Watson PG. Topical flurbiprofen: an effective treatment for episcleritis? Eye 1990;4:521-525
33. Wood TS, Stewart RH, Bowman RW, et al. Suprofen treatment of contact lens-associated giant papillary conjunctivitis. Ophthalmology 1988;95:822-826
34. 4 in tears of vernal conjunctivitis patients during a therapeutic trial with indomethacin. Doc Ophthalmol 1994;85:247-257
35. Ciprandi G, Buscaglia S, Cerqueti MP, et al. Topical anti-inflammatory drugs in the treatment of allergic pollinosic conjunctivitis: a comparative double-blind study. J Invest Allergol Clin Immunol 1992;2(5):248-252
36. Ballas Z, Blumenthal M, Tinkelman DG, et al. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993;38:141-148
37. Tinkelman DG, Rupp G, Kaufman H, et al. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993;38(suppl):113-140
38. Arshinoff S, D'Addario D, Sadler C, et al. Use of topical nonsteroidal anti-inflammatory drugs in excimer laser photorefractive keratectomy. J Cataract Refract Surg 1994;20:216-222
39. Frucht-Perry J, Levinger S, Zankerman H. The effect of topical administration of indomethacin on symptoms in corneal scars and edema. Am J Ophthalmol 1991; 112:186-190